Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 157.2 | 153.0 | 123.8 | 65.8 | 56.4 |
Revenue growth | 2.8% | 23.6% | | 16.7% | |
Cost of goods sold | 40.6 | 34.9 | 38.5 | 31.9 | 35.8 |
Gross profit | 116.6 | 118.1 | 85.3 | 33.9 | 20.6 |
Gross margin | 74.2% | 77.2% | 68.9% | 51.5% | 36.5% |
Sales and marketing | 82.5 | 77.5 | 43.5 | 3.2 | 3.3 |
Research and development | 1.3 | 0.9 | 0.7 | 0.7 | 0.5 |
General and administrative | 5.9 | 3.3 | 5.5 | 3.1 | 3.0 |
EBITA | 29.5 | 38.3 | 33.4 | 27.4 | 13.8 |
EBITA margin | 18.8% | 25.0% | 27.0% | 41.6% | 24.5% |
Amortization of intangibles | 2.8 | 2.0 | 2.8 | 0.5 | |
EBIT | 26.7 | 36.3 | 30.7 | 26.8 | 13.8 |
EBIT margin | 17.0% | 23.7% | 24.8% | 40.8% | 24.5% |
Pre-tax income | 26.9 | 36.3 | 50.6 | 26.6 | 13.6 |
Income taxes | 0.4 | 1.0 | 1.7 | 0.2 | -0.1 |
Tax rate | 1.5% | 2.7% | 3.3% | 0.7% | |
Net income | 26.4 | 35.4 | 49.0 | 26.4 | 13.7 |
Net margin | 16.8% | 23.1% | 39.6% | 40.1% | 24.3% |
|
Diluted EPS | $0.39 | $0.54 | $0.83 | $0.57 | $2.08 |
Shares outstanding (diluted) | 68.1 | 65.4 | 59.1 | 46.5 | 6.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|